Intra--arterial chemotherapy in the management of advanced maxillary sinus cancer.

Abstract	Presented is an update on the current role of intra-arterial chemotherapy in the management of advanced maxillary sinus cancer. The potential benefit of such chemotherapy is that it permits the delivery of a high concentration of the cytotoxic agent directly to the tumour tissue bed in an effort to maximize the cytotoxicity and minimize the side effects. In such circumstances it is feasible to omit mutilating surgery and treat under an organ-sparing protocol without compromising survival.
Authors	R S Greval, S C Goyal, J R Sofat
Journal	Indian journal of medical sciences (Indian J Med Sci) Vol. 47 Issue 7 Pg. 173-6 (Jul 1993) ISSN: 0019-5359 [Print] India
PMID	8258472 (Publication Type: Journal Article, Review)
Chemical References	Antineoplastic Agents
Topics	Antineoplastic Agents (administration & dosage) Carcinoma (drug therapy) Female Humans Infusions, Intra-Arterial Male Maxillary Sinus Neoplasms (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!